Home › Funds › SPHERA FUNDS MANAGEMENT LTD. › CLYM
SPHERA FUNDS MANAGEMENT LTD. position in CLYM
CLIMB BIO INC · Health Care
SPHERA FUNDS MANAGEMENT LTD. reported holding 416,747 shares of CLYM (CLIMB BIO INC) in its Q3 2026 13F filing — a position valued at US$4.8M, representing 0.74% of its reported portfolio and ranking #40 among its reported holdings. SPHERA FUNDS MANAGEMENT LTD. has disclosed CLYM holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How SPHERA FUNDS MANAGEMENT LTD.'s CLYM position evolved
SPHERA FUNDS MANAGEMENT LTD. first disclosed a stake in CLYM in Q2 2024 at 215,179 shares (US$1.5M). The position peaked in Q2 2026 at 483,747 shares, worth US$6.3M. Across 10 filings, SPHERA FUNDS MANAGEMENT LTD. increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 416,747 shares valued at US$4.8M — a reduction of -67,000 shares quarter over quarter.. Notable position changes include a 107% increase in Q3 2025 (shares rose 99% over the following quarter), a 114% increase in Q4 2025 (shares rose 71% over the following quarter), a 55% trim in Q1 2026 (shares rose 90% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 215.18K | $1.53M | New |
| Q3 2024 | 181.97K | $926.23K | Reduce |
| Q4 2024 | 251.94K | $453.48K | Add |
| Q1 2025 | 241.94K | $295.16K | Reduce |
| Q2 2025 | 209.84K | $260.20K | Reduce |
| Q3 2025 | 434.84K | $874.02K | Add |
| Q4 2025 | 932.25K | $3.73M | Add |
| Q1 2026 | 419.25K | $2.87M | Reduce |
| Q2 2026 | 483.75K | $6.31M | Add |
| Q3 2026 | 416.75K | $4.78M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CLYM and 13F data
CLYM (CLIMB BIO INC) is a Health Care company. 68 other funds we track also report a position in CLYM — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$116.2M), BRAIDWELL LP (US$32.8M), Cormorant Asset Management, LP (US$24.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CLYM
- RA CAPITAL MANAGEMENT, L.P. 10.13M sh · $116.19M · Q3 2026
- BRAIDWELL LP 2.86M sh · $32.84M · Q3 2026
- Cormorant Asset Management, LP 2.11M sh · $24.16M · Q3 2026
- Redmile Group, LLC 974.49K sh · $11.18M · Q3 2026
- Affinity Asset Advisors, LLC 972.00K sh · $11.15M · Q3 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 918.23K sh · $10.53M · Q3 2026
- GREAT POINT PARTNERS LLC 800.00K sh · $9.18M · Q3 2026
- NAN FUNG TRINITY (HK) Ltd 360.65K sh · $4.14M · Q3 2026
- ArchPoint Investors 132.90K sh · $1.52M · Q3 2026
- Exome Asset Management LLC 71.22K sh · $816.84K · Q3 2026
More on SPHERA FUNDS MANAGEMENT LTD.
FAQ
How long has SPHERA FUNDS MANAGEMENT LTD. held CLYM?
SPHERA FUNDS MANAGEMENT LTD. has disclosed CLYM holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is SPHERA FUNDS MANAGEMENT LTD.'s current position in CLYM?
As of Q3 2026, SPHERA FUNDS MANAGEMENT LTD. holds 416.75K shares of CLYM (CLIMB BIO INC), valued at $4.78M, representing 0.74% of its reported portfolio and ranking #40.
Has SPHERA FUNDS MANAGEMENT LTD. been buying or selling CLYM?
In the latest 13F filing (Q3 2026), SPHERA FUNDS MANAGEMENT LTD. reduced its position in CLYM. The position peaked in Q2 2026 at 483.75K shares.
Which other funds hold CLYM?
Other major institutional holders of CLYM include RA CAPITAL MANAGEMENT, L.P., BRAIDWELL LP, Cormorant Asset Management, LP, among 68 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.